HUP0104273A2 - Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények - Google Patents

Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP0104273A2
HUP0104273A2 HU0104273A HUP0104273A HUP0104273A2 HU P0104273 A2 HUP0104273 A2 HU P0104273A2 HU 0104273 A HU0104273 A HU 0104273A HU P0104273 A HUP0104273 A HU P0104273A HU P0104273 A2 HUP0104273 A2 HU P0104273A2
Authority
HU
Hungary
Prior art keywords
semi
pharmaceutical compositions
compositions containing
synthetic
ecteinascidins
Prior art date
Application number
HU0104273A
Other languages
English (en)
Inventor
Jose J. Morales
Kenneth L. Rinehart
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of HUP0104273A2 publication Critical patent/HUP0104273A2/hu
Publication of HUP0104273A3 publication Critical patent/HUP0104273A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A találmány számos új szemiszintetikus ecteinascidin- (Et)származékra, éspedig az itt Et 757, Boc-Et 729, Izo-Et 743, Et 875 ésEt 1560 jelölésekkel jelzett, rendre az (I), (II), (III), (IV) és (V)képlettel jelölt származékokra, valamint ezeket tartalmazó gyógyászatikészítményekre és ezek tumorellenes alkalmazására vonatkozik. Ó
HU0104273A 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins and pharmaceutical compositions containing them HUP0104273A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06
PCT/US1999/007471 WO1999051238A1 (en) 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins

Publications (2)

Publication Number Publication Date
HUP0104273A2 true HUP0104273A2 (hu) 2002-03-28
HUP0104273A3 HUP0104273A3 (en) 2003-12-29

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104273A HUP0104273A3 (en) 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US6124293A (hu)
EP (2) EP1876180A3 (hu)
JP (1) JP4443043B2 (hu)
KR (1) KR100603219B1 (hu)
CN (1) CN1157189C (hu)
AT (1) ATE370148T1 (hu)
AU (1) AU758100B2 (hu)
BG (1) BG65088B1 (hu)
BR (1) BR9909488B1 (hu)
CA (1) CA2327468C (hu)
CY (1) CY1106988T1 (hu)
CZ (1) CZ301083B6 (hu)
DE (1) DE69936845T2 (hu)
DK (1) DK1067933T3 (hu)
ES (1) ES2292237T3 (hu)
HK (1) HK1033651A1 (hu)
HU (1) HUP0104273A3 (hu)
IL (2) IL138856A0 (hu)
MX (1) MXPA00009840A (hu)
NO (1) NO328147B1 (hu)
NZ (1) NZ507350A (hu)
PL (1) PL196809B1 (hu)
PT (1) PT1067933E (hu)
RU (1) RU2217432C2 (hu)
SK (1) SK285669B6 (hu)
TR (1) TR200002921T2 (hu)
UA (1) UA59439C2 (hu)
WO (1) WO1999051238A1 (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
TR200003470T2 (tr) * 1998-05-11 2001-06-21 Pharama Mar, S.A. Ecteinascidin 743 Metabolitleri
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US6686470B2 (en) 2000-01-19 2004-02-03 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
WO2002040477A2 (en) * 2000-11-03 2002-05-23 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
JP4391083B2 (ja) * 2000-11-06 2009-12-24 ファルマ・マール・ソシエダード・アノニマ 効果的な抗腫瘍治療
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
DE602004016376D1 (de) * 2003-11-13 2008-10-16 Pharma Mar Sau Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
WO2005049030A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
WO2006005602A2 (en) * 2004-07-09 2006-01-19 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
WO2006035244A2 (en) * 2004-09-29 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
US20090117176A1 (en) * 2004-10-26 2009-05-07 Pharma Mar, S.A. Sociedad Unipersonal Anticancer Treatments
RU2382647C2 (ru) 2004-10-29 2010-02-27 Фарма Мар С.А., Сосьедад Униперсональ Композиции, содержащие эктинэсайдин и дисахарид
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
CA2703026A1 (en) * 2007-10-19 2009-04-23 Rafael Rosell Costa Prognostic molecular markers for et-743 treatment
LT2786753T (lt) 2010-11-12 2019-04-10 Pharma Mar S.A. Derinių terapija su antinavikiniu antibiotiku
AU2017215603A1 (en) * 2016-02-04 2018-08-09 Jiangsu Hengrui Medicine Co., Ltd. Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
BR9909488B1 (pt) 2011-02-08
KR20010074474A (ko) 2001-08-04
DK1067933T3 (da) 2007-12-27
NO20004978D0 (no) 2000-10-03
IL138856A0 (en) 2001-10-31
EP1876180A2 (en) 2008-01-09
NO328147B1 (no) 2009-12-21
IL138856A (en) 2007-07-24
CN1157189C (zh) 2004-07-14
AU3471399A (en) 1999-10-25
CZ20003650A3 (en) 2001-06-13
WO1999051238A1 (en) 1999-10-14
SK15012000A3 (sk) 2001-08-06
EP1067933B1 (en) 2007-08-15
MXPA00009840A (es) 2002-04-24
BG65088B1 (bg) 2007-02-28
CZ301083B6 (cs) 2009-11-04
SK285669B6 (sk) 2007-06-07
TR200002921T2 (tr) 2001-02-21
ES2292237T3 (es) 2008-03-01
KR100603219B1 (ko) 2006-07-20
BG104902A (en) 2001-07-31
BR9909488A (pt) 2000-12-26
EP1876180A3 (en) 2009-12-16
HUP0104273A3 (en) 2003-12-29
EP1067933A1 (en) 2001-01-17
CN1304309A (zh) 2001-07-18
CA2327468C (en) 2008-05-06
AU758100B2 (en) 2003-03-13
EP1067933A4 (en) 2002-12-18
PL196809B1 (pl) 2008-02-29
HK1033651A1 (en) 2001-09-14
UA59439C2 (uk) 2003-09-15
CY1106988T1 (el) 2012-09-26
JP2002510633A (ja) 2002-04-09
JP4443043B2 (ja) 2010-03-31
RU2000128058A (ru) 2004-02-20
DE69936845T2 (de) 2008-05-08
ATE370148T1 (de) 2007-09-15
WO1999051238A9 (en) 2000-01-27
NO20004978L (no) 2000-12-05
PT1067933E (pt) 2007-11-15
NZ507350A (en) 2003-03-28
CA2327468A1 (en) 1999-10-14
US6124293A (en) 2000-09-26
PL343439A1 (en) 2001-08-13
DE69936845D1 (de) 2007-09-27
RU2217432C2 (ru) 2003-11-27

Similar Documents

Publication Publication Date Title
HUP0104273A2 (hu) Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
ZA875179B (en) Taxol derivatives,their preparation and pharmaceutical compositions containing them
NO943002L (no) Fosfono-oksymetyletere av taxanderivater
HUP0100949A2 (hu) Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények
FI952920A0 (fi) 7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
DE69940674D1 (de) Orale verabreichung von adenosin analogen
ATE2667T1 (de) Antidepressiv wirkende derivate des trans-4phenyl-1,2,3,4-tetrahydro-1-naphthalin-amins und pharmazeutische zusammensetzungen daraus.
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
HUP0103590A2 (hu) Nukleofilszubsztitutált ekteinaszcidinek és N-oxid-ekteinaszcidinek, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
ES2123996T3 (es) Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.
HUP0101960A2 (hu) Az ekteinaszcidin 743 metabolitjai, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
ES2181824T3 (es) Profarmacos de derivados de paclitaxel.
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
HUP0200055A2 (hu) 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
NO20006230L (no) Hyperforinderivater, anvendelsen derav og formuleringer inneholdende dem
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
ES466057A1 (es) Un procedimiento para preparar compuestos de 4"-desoxi-4"- amino-eritromicina a.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees